Detecting: ORF1ab, N gene, E gene, Inner ControlSample Type: Oral swab/Nasal swabStorage: -20°CReaction Volume: Volume: 30μlSensitivity: 200 copies/mlHighlights:Maxmize your testing capacity with Super Fast PCR Kit 3 times more efficient than regular kitsFeatures:Fast: Complete all steps within 30 minutes by Singu9600 ProAccurate: Detecting…
Highlights:MolGen’s DNA/RNA kits are optimized for high-quality, high throughput DNA/RNA extraction and purification to isolate NA. The Pathogens kit isolates DNA or RNA from a large variety of sample matrices like blood, plasma, serum, urine, swab washes, tissue samples and feces. Our animal, seed, and leaf kits can be customized to extract DNA/RNA from a large variety of sample matrices.…
Dimensions: 533.4 × 355.6 × 533.4 mm (w × h × d)Weight: 27 kgSample throughput: up to 48 samples /25 – 75 minutesAssays: Blood, FFPE, buffy coat, bone marrow, buccal swabs, urine etc. (CE-IVD) or stool, tissue, food, and many more (RUO) Highlights: Automated nucleic acid extraction – IVDR-compliant Extraction of high-quality nucleic acid with…
Dimensions: 330.2 × 299.7 × 345.2 mm (w × h × d)Weight: 11 kgSample througput: up to 16 samples / 25 – 75 minutesAssays: Blood, FFPE, buffy coat, bone marrow, cells, serum, urine etc. (CE-IVD) or stool, tissue, food, and many more (RUO) Highlights: Automated DNA and RNA extraction – IVDR-compliant Generates consistent, high-quality nucleic…
Dimensions: 650 × 600 × 690 mm (w × h × d)Weight: 60 kgSample througput: flexible: 1 to 12 samples / run Highlights:SelectNAplus is Molzym’s unique bench top instrument for the automated enrichment and isolation of bacterial & fungal DNA from complex specimens.Walk-away pathogen DNA isolationHuman DNA depletion (MolYsis technology) for enhanced…
Highlights:Validated containers for saliva collection for virus diagnostics: Monovette VD, V-Monovette VD and Salivette VD.Saliva testing has become particularly important and is ideal for screening for SARS-CoV-2. Saliva collection using gargling and/or the Salivette offers the key advantage that the user can collect the saliva themselves under supervision.Both the gargling and the Salivette…
Highlights:One swab, three results—know with confidenceReliable results in 15 minutes to facilitate immediate patient treatment.When your patients present with a fever, cough, and other common respiratory symptoms, choosing the appropriate treatment requires determining the cause of their illness. The Clinitest Rapid Covid-19 + Influenza Antigen Test, distributed by Siemens…
Dimensions: 316 × 340 × 220 mm (w × d × h)Weight: 8 kgSample Throughput: 32 Samples/h (4×8 wells, dual module)Number of Channels: 4Highlights:The AccuRa-32 is specifically designed for rapid nucleic acid testing in applications such as clinical, food, environmental and research. It is supported by highly sensitive fluorescence measurements in real…
Speed or accuracy? As far as Covid-19 tests go, this was the choice you had to make. In the future, this dilemma could be a thing of the past.
What if a test analysing cervical cells from a gynaecological swab could be used to detect four different female cancers at an early stage and also predict cancer risk over a healthy woman's lifetime? Researchers at the EUTOPS Institute in Innsbruck, Austria, are developing tests to do just that for breast, ovarian, cervical, and endometrial cancer detection.
Using a newly launched, comprehensive monkeypox registry, health professionals can share data on the skin symptoms of monkeypox and the vaccine to improve patient care.
Skin swabs are "surprisingly effective" at identifying Covid-19 infection, according to new research, offering a route to a non-invasive future for Covid-19 testing.
Handheld, instrument-free test delivers lab-quality molecular results – 97.9% accuracy – in about 15 minutes, right at the point of care.
By comparing the infectious viral load caused by ancestral SARS-CoV-2 as well as by the Delta and Omicron variants, scientists highlight the benefits of vaccination.
SARS-CoV-2 has heavily impacted global society with high pressure on public health and economics. MolGen is proud to assist in relieving some of the pressure and support the testing framework.
The MD-Bio BCC19 Coronavirus test utilizes RT-LAMP technology to provide accurate results in just 30 minutes.
Combining questions about a person's health with data from smartwatch sensors, a new app can predict within minutes whether someone is infected with COVID-19.
Traces of the SARS-CoV-2 coronavirus that causes COVID-19 can be detected in microscopically small fluid droplets exhaled during a very short time span.
The tool has made it possible to detect SARS-CoV-2 in exudate from symptomatic patients with a sensitivity of 100% and a specificity of 87.5%
With micro-organisms and viruses constantly developing, mutating, and evolving, diagnostics must adapt just as rapidly. Advanced laboratory technology and instruments are undeniably a prerequisite for best practice in life sciences and biotechnology.
Researchers have developed a noninvasive and reagent-free technique for the efficient detection of COVID-19.
Researchers have developed a diagnostic for SARS-CoV-2 that is capable of differentiating between COVID-19 and the garden-variety bug with fast turnaround.
A type of the antibiotic resistant superbug MRSA arose in nature long before the use of antibiotics in humans and livestock, which has traditionally been blamed for its emergence.
Founded in 2018 as a DNA extraction chemistry company, Dutch company MolGen entered the market operating within the agricultural sector. At first, the company’s founders, Maarten de Groot, Wim van Haeringen and Niels Kruize, focused solely on this one industry, mainly developing and marketing advanced bulk chemistry kits for DNA/RNA extraction. These testing products and solutions successfully…
In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus.
Compared to previous SARS and MERS, SARS-CoV-2 became a pandemic due to the high infectivity and different mode of contagion. SARS-CoV-2 spreads more because it is contagious also before symptoms, during incubation phase. No tests to date have been able to find the virus during the pre-symptomatic stage. Stark has developed a new, rapid, non-invasive method "Stark Portable Covid-19 Antigen…
Study suggests need for better ventilation and tight-fitting masks, in addition to widespread vaccination to help stop spread of the virus.
Obtaining two vaccine doses remains the most effective way to ensure protection against the Covid-19 Delta variant of concern dominant in the UK today, according to a study from the University of Oxford. Conducted in partnership with the Office of National Statistics (ONS) and the Department for Health and Social Care (DHSC), the study found that with Delta, Pfizer-BioNTech and Oxford-AstraZeneca…
An international research team from Saudi Arabia, Germany, and Jordan has developed a novel pathogen aptasensor swab designed to qualitatively detect, within five minutes, any methicillin-resistant Staphylococcus aureus (MRSA) contamination that remains in a hospital isolation room or other surface following standard decontamination and cleaning.
A low-cost, rapid diagnostic test for Covid-19 developed by Penn Medicine provides Covid-19 results within four minutes with 90 percent accuracy. A paper published this week in Matter details the fast and inexpensive diagnostic test, called RAPID 1.0 (Real-time Accurate Portable Impedimetric Detection prototype 1.0). Compared to existing methods for Covid-19 detection, RAPID is inexpensive and…
Now Available: The Fluxergy Analyzer System is a testing platform designed for sample-to-answer point-of-care testing, enabling clinicians to cost-effectively conduct molecular in vitro diagnostic tests. The analyzer system is designed to deliver test results within one hour. This device is solely intended to be used by healthcare professionals.
Clinicians using a new viral screening test can not only diagnose Covid-19 in a matter of minutes with a portable, pocket-sized machine, but can also simultaneously test for other viruses—like influenza—that might be mistaken for the coronavirus. At the same time, they can sequence the virus, providing valuable information on the spread of Covid-19 mutations and variants. The new test, dubbed…
A University of Manchester team has applied new techniques to detect and track the transmission of Covid-19 in hospital. The proof of concept system combines the movement and interaction of staff and patients with genomic sequencing of the virus, helping to signpost how best to improve patient pathways, staff movement and reduce risk. They identified hotspots within hospitals where patients and…
Skin swab samples analysed using mass spectrometry could be used to detect Covid-19 in patients, according to research conducted at the University of Surrey in the UK. Current Covid-19 testing is via a polymerase chain reaction (PCR) test, which involves taking a swab of the back of the throat and inside the nose, but the team from Surrey - working with Frimley NHS Trust and the Universities of…
Rapid tests, PCR tests, self-tests… there are many test options to determine contamination with Covid-19. In most this is done by inserting a cotton swab deep into the nose and/or throat to extract some mucus – unpleasant for adults and often a drama for children. Towards the end of 2020, a new system emerged to rule out a Covid-19 contamination. The electronic SpiroNose performs a…
It is possible to identify Parkinson’s Disease based on compounds found on the surface of skin, according to new research. The findings offer hope that a pioneering new test could be developed to diagnose the degenerative condition through a simple and painless skin swab. Scientists at The University of Manchester have developed a technique which works by analysing compounds found in sebum -…
In order to monitor and contain the spread of SARS-CoV-2 it is necessary to test large numbers of people on a regular basis in decentralized settings. Researchers of the Max Planck Institute for Evolutionary Anthropology and the Hospital St. Georg in Leipzig, Germany, have developed improved protocols for the detection of SARS-CoV-2. The method can detect a positive sample in a pool with 25…
In the era of social distancing, using robots for some health care interactions is a promising way to reduce in-person contact between health care workers and sick patients. However, a key question that needs to be answered is how patients will react to a robot entering the exam room. Researchers from MIT and Brigham and Women’s Hospital recently set out to answer that question. In a study…
To date, testing for SARS-CoV-2 infection mostly has relied on RT-PCR performed on a nasopharyngeal specimen. This testing method is very unpleasant for a patient: the professional tester has to tilt the patient’s head back slightly about 45°-70° to straighten the passage from the front of the nose, insert the swab through the nostril parallel to the palate, and the swab should reach a depth…
The PCR test is the most accurate tool to identify SARS-CoV-2. However, valid results are often available only after days. Moreover, the laboratory must be well equipped, have trained personnel and sufficient financial resources. All of this is usually a problem in Africa. A portable suitcase could help. In cooperation with several African universities, scientists at Leipzig University have found…
Wearable devices can identify Covid-19 cases earlier than traditional diagnostic methods and can help track and improve management of the disease, Mount Sinai researchers report in one of the first studies on the topic. The findings were published in the Journal of Medical Internet Research. The Warrior Watch Study found that subtle changes in a participant’s heart rate variability (HRV)…
Researchers at the University of Arizona are developing a Covid-19 testing method that uses a smartphone microscope to analyze saliva samples and deliver results in about 10 minutes. The research team, led by biomedical engineering professor Jeong-Yeol Yoon, aims to combine the speed of existing nasal swab antigen tests with the high accuracy of nasal swab PCR, or polymerase chain reaction,…
The emergence of SARS-CoV-2 virus variants that are adding twists in the battle against COVID-19 highlight the need for better genomic monitoring of the virus, says Katia Koelle, associate professor of biology at Emory University.
Siemens Healthineers announced CE mark has been achieved to use anterior nose swab sampling for the Clinitest Rapid Covid-19 Antigen test. This sampling method can be less cumbersome and time consuming for both the provider and the patient. The test is a point-of-care cassette test that does not require laboratory instruments or specialized lab personnel to administer, and it delivers results in…
Hundreds of thousands of cervical cancer cases per year could be prevented through widespread vaccinations for human papillomavirus (HPV) and annual pap smear tests, says an expert at a top American hospital, Cleveland Clinic, marking Cervical Cancer Awareness Month in January. Dr. Robert DeBernardo, Section Head of Gynecologic Oncology and Vice Chair Subspecialty Care for Women’s Health at…
An Artificial Intelligence test has been shown to be able to rapidly screen patients arriving in Emergency Departments for Covid-19, using clinical information routinely available within the first hour of coming to hospital. Results of the CURIAL study, published in The Lancet Digital Health, show that the AI test correctly predicted the Covid-19 status of 92.3% of patients coming to Emergency…
RSNA 2020: International experts showcased new studies on chest CT’s role in Covid-19 diagnosis and treatment. A staggering volume of work and has been produced on the pandemic this year, with an average 367 Covid-19 journal articles published per week, according to Michael Chung, Assistant professor of radiology at Icahn School of Medicine at Mount Sinai, NYC.
A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again, for at least six months following their first infection. The study, done as part of a major collaboration between the University of Oxford and Oxford University Hospitals (OUH) NHS Foundation Trust, was published as a pre-print.
A UK biotech laboratory has used mass spectrometry in a new approach to coronavirus testing. MAP Sciences developed a gargle test, which collects samples from the back of the throat, and avoids the unpleasant sensation of the current PCR (polymerase chain reaction) swab tests. From there, the sample is tested for coronavirus using mass spectrometry (MS) with high levels of accuracy.
Russian tech company Connectome.ai is bringing its innovative Directiva.ai hand hygiene teaching and monitoring system to two major clinics owned by the European Medical Center group, the leading private healthcare provider in Moscow and the surrounding region.
Merck announced a collaboration with Mammoth Biosciences Inc. for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test.
Research and innovation hub Imec announced that it has started developing a groundbreaking SARS-CoV-2 test. Unlike current approaches (using blood, saliva, or a nasopharyngeal swab), the new test will identify SARS-CoV-2 virus particles in a person’s exhaled breath. The solution promises the accurate identification of a contagious case in less than five minutes.
A new mobile app has made it possible to analyse the genome of the SARS-CoV-2 virus on a smartphone in less than half an hour.
People with ‘silent’ COVID-19 infection have as much coronavirus in their noses and throats as those with symptoms, reveals research published online in the journal Thorax. Given how many of these people there are---a fifth of those infected, the study findings show--they may have a key role in driving the spread of COVID-19, warn the researchers, who go on to suggest that this warrants…
Ultrasound could become the prime modality in emergency settings for tracking disease progression in COVID-19 patients. While chest CT has held a key diagnostic role thus far, many experts now advocate the benefits of ultrasound within the context of the coronavirus epidemic. Dr Rachel Liu, who recently led a high-profile panel discussion with experts from the USA and areas of Europe with high…
Contrary to expectations, the risk of COVID-19 infection among hospital staff at the height of the coronavirus pandemic was lowest among intensive care clinicians, reveals a study of one major UK medical centre, published in the journal Thorax.
As COVID-19 continues to spread, bottlenecks in supplies and laboratory personnel have led to long waiting times for results in some areas. In a new study, University of Illinois, Urbana-Champaign researchers have demonstrated a prototype of a rapid COVID-19 molecular test and a simple-to-use, portable instrument for reading the results with a smartphone in 30 minutes, which could enable…
In the most comprehensive study of COVID-19 pediatric patients to date, Massachusetts General Hospital (MGH) and Mass General Hospital for Children (MGHfC) researchers provide critical data showing that children play a larger role in the community spread of COVID-19 than previously thought. In a study of 192 children ages 0-22, 49 children tested positive for SARS-CoV-2, and an additional 18…
Medical device approved 3-D printers are producing clinically safe and effective nasopharyngeal swabs for COVID-19 testing. A nasal swab may seem rudimentary, but is essential for testing COVID-19. Diagnostic test kits and components – nasal swabs, collection vials, and chemical reagents – have been in short supply worldwide, especially in March. Ironically, nasopharyngeal swabs are…
A rather unique trial in the UK currently explores the capability of dogs to detect coronavirus infections in humans with their highly sensitive noses. The researchers are asking people in England for help with the trial. Led by the ARCTEC team at the London School of Hygiene & Tropical Medicine (LSHTM) in collaboration with the charity Medical Detection Dogs and Durham University, the trial…
EKF Diagnostics, the global in vitro diagnostics company, announces that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range.
Artificial Intelligence is an essential tool for the healthcare operators on the front line in the fight against the Coronavirus pandemic. ASST Vimercate Hospital chose and implemented in the midst of the COVID-19 emergency REiLI, Fujifilm Medical Systems’ Artificial Intelligence.
When infected by the new coronavirus, women may mount a more potent adaptive immune response than do men, a new study suggests. By comparison, the male immune response appears to progress less effectively, fostering inflammation that’s harmful to the body. This study is the first to delve into sex differences in how the immune system defends itself against the virus SARS-CoV-2. It could help…
To develop and manufacture COVID-19 test kits in massive quantities was not part of their 2020 business plans. Yet, as the epidemic evolved into a global pandemic, the urgent need for diagnostic and antibody SARS-CoV-2 test kits triggered an unprecedented scramble among medical manufacturers.
A new diagnostic test can detect the RNA of SARS-CoV-2, the virus that causes COVID-19, in urine, blood, saliva or mouth swab samples in just 30 to 45 minutes, according to a new study in the open-access journal PLOS ONE by Laura Lamb of the Beaumont Health System, Michigan, USA, and colleagues.
The prevalence of ‘silent’ symptomless COVID-19 infection may be much higher than thought, reveals a study charting the enforced isolation of cruise ship passengers during the current pandemic, and published online in the journal Thorax. More than eight out of 10 of passengers and crew who tested positive for the infection had no symptoms. This has implications for the easing of lockdown…
Siemens Healthineers announced today that it is now shipping worldwide its laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 IgM and IgG antibodies in blood.
The novel Coronavirus infection (severe acute respiratory syndrome SARS-CoV-2), which has led to the spread of COVID-19 around the world, has upset normal workflow in hospitals. The increased workload and stress, due to the necessity of implementing safe and separate diagnostic pathways, and the need to constantly monitor the development of the disease after its onset, continues to have a…
A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells change upon infection with SARS-CoV-2, the virus causing COVID-19 in people. The scientists tested a series of compounds in laboratory models and found some which slowed down or stopped virus reproduction. These results now enable the search for an active substance…
Establishing whether a patient is suffering from severe lung disease, possibly COVID-19, within a few minutes: this is possible using fairly simple ultrasound machines that are enhanced with artificial intelligence. A research team at Eindhoven University of Technology (TU/e) and the University of Trento in Italy has been able to translate the expertise of top lung specialists into a software…
European photonics scientists are developing an ultrasensitive laser sensor that detects coronavirus at the earliest point of infection from a saliva or nasal swab in minutes.
Researchers at the German Red Cross Blood Donor Service in Frankfurt headed by Professor Erhard Seifried, and the Institute for Medical Virology at the University Hospital Frankfurt at Goethe University headed by Professor Sandra Ciesek succeeded in developing a procedure that makes it possible to immediately and dramatically increase worldwide testing capacities for detecting SARS-CoV-2.
The world’s only online image-based COVID-19 diagnosis improvement tool for healthcare workers is launched by University of Sydney spinoff DetectED-X, drawing on its global experience and outcomes in breast cancer detection and patient cases from the coronavirus pandemic. The cloud-based technology will help doctors and radiologists diagnose cases faster and more accurately. Computed tomography…
In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared. The research letter was published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
French in vitro diagnostics company bioMérieux announced that its subsidiary, BioFire Defense, has received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration of its BioFire COVID-19 test for use in CLIA moderate and high complexity clinical laboratories to detect the novel coronavirus SARS-CoV-2. The test detects SARS-CoV-2 in approximately 45 minutes from a…
A coronavirus app coupled with machine intelligence will soon enable an individual to get an at-home risk assessment based on how they feel and where they’ve been in about a minute, and direct those deemed at risk to the nearest definitive testing facility, investigators say. It will also help provide local and public health officials with real time information on emerging demographics of those…
In a study of more than 1,000 patients published in Radiology, chest CT outperformed lab testing in the diagnosis of 2019 novel coronavirus disease (COVID-19). Researchers at Tongji Hospital in Wuhan, China, concluded that CT should be used as the primary screening tool for COVID-19. In the absence of specific therapeutic drugs or vaccines for COVID-19, it is essential to detect the disease at an…
Martin Möckel and Dorothee Riedlinger, from the Charité Medical University Berlin, Emergency and Acute Medicine Campus Virchow-Klinikum, and Campus Charité-Mitte report on POCT testing in the A&E Department to screen for Staphylococcus aureus colonisation of the nose or throat. People colonised with Staphylococci are at increased risk of developing a nosocomial, i.e. hospital acquired…
Healthcare is going digital worldwide at an incredibly rapid pace. More and more applications for prevention, diagnostics and therapy are being made into apps (with matching hardware) for smartphones and tablets or are even available as wearables for direct use on the body. Digitalisation is also striding forward in Germany, where doctors, therapists and patients still take a fairly analogue…
Researchers from Northwestern University are using Argonne supercomputers to advance the development of an optical microscopy technique that can predict and quantify cancer risks at extremely early stages. The basic principle driving Allen Taflove’s computational electrodynamics research — which bears the potential to transform how we diagnose, and possibly treat, various forms of cancer —…
A study has identified chemicals in the skin responsible for a unique scent in people with Parkinson’s disease. The chemicals can be detected in an oily substance secreted from the skin called sebum, the researchers found. The findings suggest Parkinson’s disease could one day be diagnosed from skin swabs, potentially leading to new tests. There are no tests for Parkinson’s disease at…
The lab-in-the-box design of LabTurbo SP-qPCR All-in-one system offers true automation for the molecular laboratory, the manufacturer reports, adding that this ‘delivers testing confidence and laboratory efficiency. LabTurbo fully automates the complete workflow of molecular diagnostic laboratories. The sample-to-result procedure includes: automatic sample transfer from primary tubes, DNA/RNA…
Hologic, Inc. announced that its Panther Fusion Bordetella assay has received CE mark in Europe. This assay, the latest in a growing menu of Panther Fusion and Aptima assays, brings full automation, efficiency and excellent assay performance to Bordetella (whooping cough) detection. The Panther Fusion system retains all the key benefits of the Panther platform, including full sample-to-result…
More than a million neonatal deaths worldwide each year are estimated to be due to sepsis. In the UK there are approximately 90,000 admissions to neonatal intensive care units per year. Nearly all these patients receive antibiotic therapy during their hospital stay, but babies with a specific genetic change can suffer irreversible hearing loss as a result. Now, in a collaboration between…
This platform enables you to perform high class molecular diagnostics at an unbelievable speed. All assay run times are as short as 15 to 30 minutes, depending on the sample material. The lyophilised reactions are shippable and storable at room temperature and ready to use, with a shelf life of 18 month. Due to the robustness of the polymerase you don’t need any DNA extraction. The…
Respiratory infections peak during the winter months, and most people recover within a few weeks. But for those with a rare genetic lung disease, the sniffling, coughing and congestion never end. The tiny hairlike structures called cilia that normally sweep mucus through the airways don’t work properly in people with what’s known as primary ciliary dyskinesia. When the cilia don’t brush…
It is wartime. You and your fellow refugees are hiding from enemy soldiers, when a baby begins to cry. You cover her mouth to block the sound. If you remove your hand, her crying will draw the attention of the soldiers, who will kill everyone. If you smother the child, you’ll save yourself and the others. If you were in that situation, which was dramatized in the final episode of the ’70s and…
Smith & Nephew, the global medical technology business, announces the European launch of MolecuLight i:X, the easy to use, handheld imaging device that instantly measures wound surface area and visualises the presence and distribution of potentially harmful bacteria in wounds. Currently wound assessments are made with the naked eye which can lack the accuracy required to most effectively…
Saliva is no way to pass a Zika virus infection. According to researchers at the University of Wisconsin–Madison who conducted studies with monkeys, casual contact like kissing or sharing a fork or spoon is not enough for the virus to move between hosts.
Airports are international travel hubs visited by large numbers of people. London Heathrow, for example, has an average of 205,400 travellers every day and saw 75 million people arriving and departing from all over the world in 2015. A study just published in the journal Clinical Microbiology and Infection suggest that international travellers can acquire antimicrobial-resistant bacteria and may…
Curetis N.V. announced the successful completion of the CE Performance Evaluation study of the next generation of its Unyvero ITI Implant and Tissue Infection Application Cartridge (Unyvero ITI).
A debate has flared up across the United Kingdom over which genre of music should be played in the operating theatre during surgery. Amid claims that loud music can be distracting to some surgical personnel, questions have also been posed as to who should choose the music – the head surgeon or nurse? How loud it should be played, or should music is permissible in the operating theatre (OT) at…
The yuck factor may be an effective tool for boosting hand hygiene compliance among health care workers, according to a study at Henry Ford Hospital in Detroit.
“These dates we have access to a lot of genetic information which had previously not been available to us. For the individual, this can provide options for action with regards to leading a healthier lifestyle or to try and prevent diseases,” knows Dr. Theodor Dingermann. The senior professor of the Goethe University in Frankfurt am Main has had his own genome decoded. In parts, the result…
Prosthetic joint infections (PJI) are the most frequent complication in orthopaedic implant patients and may occur any time: weeks, months, or even years after an implantation. Report: Ludger Weß
Trichomonias, with an estimated 187 million cases, and Chlamydia with around 100 million, are the most prevalent sexually transmitted diseases (STDs), according to the World Health Organisation (WHO). There are approximately 36 million cases each of gonorrhoea and syphilis. HIV1/2 cases are around 34 million. Report: Cynthia Keen
The human gut literally teems with microorganisms from at least 1,000 different species that are increasingly considered to be a valuable resource for the prediction, aetiology and prognosis of disease. Due to continual contact with the environment, primarily via food, the gut is susceptible to infection when a virus, parasite or bacterium enters and disrupts normal gut microbiota (or flora).
Personalised medicine is often equated with the development of drugs tailored to the genetic make-up of patients or cancers.
Run by Sheffield Teaching Hospitals NHS Trust, the new automated Medical Laboratory at the Northern General Hospital has drawn a previously fragmented service into a purpose-built centre.
A new test gives reliable results in just 75 minutes, speeding up combat actions. Since Methicillin-resistant staphy lococcus aureus (MRSA) has developed resistance to antibiotic treatments, infections have become a dreaded occurrence in hospitals worldwide.
A recent webinar, hosted by the American Association of Clinical Chemistry, featured doctors Duane Newton of the University of Michigan and Susan Novak-Weekly of Kaiser Permanente.
The world’s first point-of-care wound test, unveiled last November at the Wounds UK conference, is now used by the National Health Service (NHS) -- and internationally.
Scientists in Scotland have developed a new test using a strip with electrical sensors that can show whether wounds or lesions have been infected with bacteria, including MRSA, Mark Nicholls reports. The hand-held test provides rapid results and allows almost immediate detection of bacteria, which means patients can be given more effective drugs much quicker and speed up their recovery.
Different tests bring different results, and results of the same types of test vary from laboratory to laboratory. "In the case of test procedures for autoimmune diseases there are incredible discrepancies," confirmed Professor Manfred Herold, head of the Laboratory for Rheumatism at the University Clinic for Internal Medicine One, Innsbruck. The reason: "There are no standards for…
The MRSA problem has been ignored almost stoically in many European countries for the past 20 years. Thus the number of resistant Staphylococci cases exploded from 1% in 1990 around 25% in 2010. However, the recognition that an infection can result in additional hospital costs of up to €10,000 has led to a change in thinking. The Netherlands, for example, declared war on MRSA with ‘search and…
A decade ago the battle against hospital-acquired MRSA (methicillin-resistant Staphylococcus aureus bacterial strain) infections appeared to be lost, or at least without end. However, today, we see very important science-to-business achievements in this field. Report: Rostislav Kuklik
How the PCR-Test works The MRSA bacterium contains an additional 'mobile gene cassette' (SCCmec cassette) in its genetic makeup, which contains the so-called mecA gene. All beta-Lactam antibiotics such as Methicillin are therefore no longer effective. The LightCycler MRSA Advanced Test facilitates the detection of all five known SCCmec types within 85 to 100 minutes. This test principle is based…
Surgeons using technology-supported surgical systems, e.g. lasers and robotics, are challenged not to lose sight of the human element, which influenced the theme Humanity through technology for the 126th Annual Congress of the German Society for Surgery (DGCH) held in Munich this April.
Marcel van Kasteel MBA, is VP of Philips and CEO of Handheld Immunoassays, a Philips Incubator venture in Eindhoven, the Netherlands, which recently announced that, by the end of this year, the first device to test for drug abuse will be marketed that will make on the spot testing simple and quick for use by the police.
Regulars at MEDICA well understand the energy needed to stay the pace. A welcome break at the end of the days could be found at the receptions or `Happy Hours´ held by certain exhibitors who will be happy to welcome visitors to their stands.
Researchers funded by the European Union have devised OptoLabCard, a system that prepares samples and performs DNA tests on bacteria in a portable, easily used, cost-effective lab-on-a-chip.
Report: Mark Nicholls
An estimated 92 million Chlamydia trachomatis infections occur annually. Often, this disease presents no clear symptoms. Inverness Medical reports that its Clearview Chlamydia MF test can provide a diagnosis in as little as 30 minutes, so that, during a single visit, a patient can also begin treatment.
The NHS is still suffering from wide variations in infection control standards, according to a survey of health staff in the UK. The study carried out by the watchdog body the Healthcare Commission, after questioning more than 155,000 NHS staff, indicated that there had been improvements in infection control in several areas.
In partnership with European Hospital, DNA Art UK will supply the winner with a 90 x 60cm canvas of his or her own DNA, in a colour selected from a choice of nine (or in customised hues)
The theatre is spectacular. Its immaculate cornflower blue glass walls surround space age technology — the EndoALPHA system. Even that name suggests something that surpasses what existed before; it's `the be all and end all´.
By performing just a single test healthcare personnel is now able to simultaneously detect eighteen of the most prevalent respiratory infections in patients. The Seeplex 18-plex Respiratory Test is a highly economical method for molecular diagnostics of respiratory infections. It achieves results rapidly at minimal costs per test.
The methicillin resistant staphylococcus aureus (MRSA) is one of the most common causes of life threatening infections among hospital patients. What makes the bacterium that dangerous is the fact, that due to unspecific symptoms and long lasting testing procedures its detection takes too long. A new test that delivers results in just five hours now offers the possibility of a MRSA screening for…
Community-acquired pneumonia (CAP) is a major health problem globally. A new test now quickly identify pathogens. BinaxNOW tests quickly identify pathogens